This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Patti, G. Articles by Di Sciascio, G. Search for Related Content PubMed PubMed Citation Articles by Patti, G. Articles by Di Sciascio, G.

Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction

Giuseppe Patti, MD^*, Andrea D'Ambrosio, MD^*, Simona Mega, MD^*, Gabriele Giorgi, MD, Enrico Maria Zardi, MD, Domenico Maria Zardi, MD, Giordano Dicuonzo, MD^*, Aldo Dobrina, MD^* and Germano Di Sciascio, MD, FACC, FESC^*,*

^* Department of Cardiovascular Sciences, Campus Bio-Medico University, Rome, Italy
Division of Cardiology, "San Sebastiano Martire" Hospital, Frascati, Italy

View larger version (29K): [in a new window]   Figure 1 Percentage of patients with elevated levels of creatine kinase (CK), CK-MB, troponin I, myoglobin, C-reactive protein (CRP), and interleukin-1 receptor antagonist (IL-1Ra) upon emergency department admission, according to chest pain duration (Cochran Q test).

View larger version (13K): [in a new window]   Figure 2 Distribution of interleukin-1 receptor antagonist (IL-1Ra) levels in patients with heralded and unheralded myocardial infarction (MI).